ABVC BIOPHARMA, INC. - 10-Q Filing
ABVC Biopharma reports $1.74M in accrued R&D expenses and notes upcoming resumption of ophthalmology and CNS clinical trials.
Tickers: $ABVC
More Regulatory news
- SusGlobal Energy Corp. - 10-Q Filing
- Ideal Power Inc. - 8-K Filing
- DIGI INTERNATIONAL INC - 8-K Filing
- ZeroStack Corp. - 8-K Filing
- Sound Point Meridian Capital, Inc. - 8-K Filing
- Boost Run Inc. - 8-K Filing
- INTERFACE INC - 8-K Filing
- Neonode Inc. - 10-Q Filing
- Virtuix Holdings Inc. - 8-K Filing
- Neonode Inc. - 8-K Filing